Consortia for Structure-based Immunogen Design for HIV (CSID-HIV) (UM1 Clinical Trial Not Allowed)
HHS-NIH11 Forecasted RFA-AI-27-020Description
The purpose of this notice of funding opportunity (NOFO) is to support coordinated, multidisciplinary research on structure-based immunogen design aimed at preventing and controlling HIV. The goal is to develop HIV immunogens and treatment strategies that use or stimulate broadly neutralizing antibodies (bNAbs), and to advance these approaches toward clinical testing for both prevention and therapy. Technologies and methods developed through this initiative are expected to have broad applications in other fields that face similar challenges in targeting antigens for therapeutics and vaccine development.
Eligibility
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations
Actions
Funding Details
- Award Floor
- Not specified
- Award Ceiling
- Not specified
- Total Estimated Funding
- Not specified
- Expected Awards
- Not specified
Key Dates
- Posted
- September 15, 2025
- Closes
- N/A
- Archive Date
- April 23, 2026
Agency Information
- Agency Name
- National Institutes of Health
- Agency Code
- HHS-NIH11
- Funding Instrument
- Other